Product Information
CYCLOSPORINE 100 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $7.5068 per EA under NDC 68084092125. Its NADAC has been published 563 times since Dec 23, 2015.
FDA first approved this application on May 9, 2002. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
American Health PackagingNDC
68084092125
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA065040FDA Approved
5/9/2002
TE Code
AB2
On Market Since
11/3/2015
Pharmacological Classes
Price Statistics
The NADAC for CYCLOSPORINE 100 MG CAPSULE has been published 563 times since Dec 23, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.5068 per EA |
|---|---|
| All-time high | $10.1788 (Dec 11, 2024) |
| All-time low | $6.3086 (Apr 20, 2022) |
| 52-week high | $8.5117 |
| 52-week low | $7.2914 |
| Median price | $8.4187 |
| Average price | $8.3522 |
| Largest weekly change | +32.4% (Jan 18, 2023) |
| Weeks tracked | 563 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyclosporine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcineurin Inhibitor Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYCLOSPORINE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE 100 MG CAPSULE, manufactured by American Health Packaging, is $7.5068 per EA (NDC 68084092125), effective Sep 30, 2026.
How has the price of CYCLOSPORINE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CYCLOSPORINE 100 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 563 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for CYCLOSPORINE 100 MG CAPSULE?
Since Dec 23, 2015, the NADAC for CYCLOSPORINE 100 MG CAPSULE has ranged from a low of $6.3086 (Apr 20, 2022) to a high of $10.1788 (Dec 11, 2024), with a median of $8.4187 per EA.
Are there cheaper alternatives to CYCLOSPORINE 100 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOSPORINE MODIFIED 100 MG, is $1.2335 per EA — about 84% below CYCLOSPORINE 100 MG CAPSULE.
Who manufactures CYCLOSPORINE 100 MG CAPSULE?
CYCLOSPORINE 100 MG CAPSULE (NDC 68084092125) is labeled by American Health Packaging, and CMS classifies it as a generic product.